Haemonetics Corporation Earnings Dividend

Haemonetics Corporation’s revenue jumped 5.6% since last year same period to $339.38Mn in the Q2 2026. On a quarterly growth basis, Haemonetics Corporation has generated -2.01% fall in its revenue since last 3-months.

Haemonetics Corporation’s net profit fell -3% since last year same period to $33.01Mn in the Q2 2026. On a quarterly growth basis, Haemonetics Corporation has generated 263.85% jump in its net profits since last 3-months.

Haemonetics Corporation’s net profit margin fell -8.14% since last year same period to 9.73% in the Q2 2026. On a quarterly growth basis, Haemonetics Corporation has generated 267.21% jump in its net profit margins since last 3-months.

Haemonetics Corporation’s earning per share (EPS) estimates for the current quarter stand at 1.07 - a -15.75% fall from last quarter’s estimates.

Haemonetics Corporation’s earning per share (EPS) estimates for the current year stand at 1.07.

Haemonetics Corporation’s earning per share (EPS) jumped 3.64% since last year same period to 1.14 in the Q2 2026. This indicates that the Haemonetics Corporation has generated 3.64% annual rate of jump in its earning per share (EPS) in the last 4 quarters.